Skip to main content

Table 2 New Classification and nomenclature of “Inactivating PTH/PTHrP Signalling Disorders” (IPPSDs) – Adapted from Position Statement EuroPHP Network 2016

From: Pseudohypoparathyroidism: application of the Italian common healthcare-pathway for a homogeneous clinical approach and a shared follow up

iPPSD

Molecular Cause

Main Features

iPPSD1

Mutations in the coding sequence of PTH1R gene

PTH resistance and/or brachydactyly

iPPSD2

Mutations in the coding sequence of GNAS gene (formerly PHP1A, PHP1C, PPHP/AHO/POH)

PTH resistance and/or subcutaneous ossifications and/or brachydactyly

iPPSD3

Abnormal methylation at the GNAS A/B:TSS-DMR (formerly PHP1B)

PTH resistance

iPPSD4

Mutations in the coding sequence of PRKAR1A gene

PTH resistance and/or brachydactyly

iPPSD5

Mutations in the coding sequence of PDE4D gene

Brachydactyly

iPPSD6

Mutations in the coding sequence of PDE3D gene

Brachydactyly +/− hypertension

  1. Abbreviations: iPPSDs Inactivating PTH/PTHrP signaling disorders